Yes. Some medicines used for chronic obstructive pulmonary disease (COPD), especially steroid tablets and high-dose steroid inhalers, can weaken bones over time and increase the chance of a fracture. The risk depends on the medicine, dose, how long it is used, and other factors such as smoking and physical activity. Most COPD medicines are not the same, so do not stop or change treatment without your prescriber.
COPD treatment helps control breathing problems, reduce airway inflammation, and manage flare-ups. However, certain medicines can affect bone strength, particularly when corticosteroids are used at high doses or over long periods. COPD itself can also be associated with a greater risk of osteoporosis, a condition in which bones become weaker and more likely to break. Understanding which medicines may affect your bones can help you discuss appropriate monitoring and prevention with your healthcare team.
Which COPD medicines can affect bone health?
The main medication-related concern is corticosteroid use. These medicines reduce inflammation in the airways, but they can also affect bones. The risk depends on whether the medicine is inhaled or taken by mouth, its dose, the duration of treatment, and your other risk factors.
Steroid tablets and oral corticosteroids
Oral corticosteroids, such as prednisolone, may be prescribed during a COPD flare-up when breathing symptoms become worse. Longer courses or repeated courses can increase the risk of osteoporosis and fractures. The NHS guidance on COPD treatment identifies weakened bones as a potential side effect of long-term steroid tablet use.
These medicines can be important for treating flare-ups, so their benefits must be weighed against their potential side effects. A short course and prolonged or repeated treatment do not necessarily carry the same risk. Tell your prescriber about previous steroid courses, including treatment received from other healthcare services, so that your overall exposure can be considered.
Inhaled corticosteroids
Some COPD inhalers contain corticosteroids, including medicines such as fluticasone or budesonide. These medicines reduce inflammation in the airways and are often combined with long-acting bronchodilators in a single inhaler. Because inhaled medicines deliver treatment directly to the lungs, generally less steroid reaches the rest of the body than with oral treatment. However, the risk of systemic side effects is not completely eliminated.
According to the NHS information about inhaled fluticasone, adults using high doses over time may have an increased risk of weak bones. The potential effect on bone health is especially worth discussing when treatment involves high doses or prolonged exposure.
Does the dose of an inhaled steroid matter?
Research suggests that the dose can make a difference. A systematic review and meta-analysis published in 2025, available through the US National Library of Medicine's PubMed database, found an association between high-dose inhaled corticosteroid use in people with COPD and increased risks of osteoporosis or fractures. The review did not find the same association for medium- and low-dose treatment in the included studies.
These findings do not mean that everyone using a high-dose inhaler will develop bone problems or that lower doses carry no possible risk. Research findings can differ according to study design, treatment exposure, and the people studied. The appropriate dose therefore depends on the individual's respiratory needs and the potential benefits and risks of treatment.
What about other COPD medicines?
Not every COPD medicine contains a corticosteroid. Bronchodilators, for example, help widen the airways by relaxing the muscles around them. Other medicines may help loosen mucus or reduce flare-ups. These treatments have different purposes and side-effect profiles, so a bone-health concern linked to corticosteroids should not automatically be applied to every medicine used for COPD.
If you use a combination inhaler, check its active ingredients with your pharmacist or prescriber. Knowing whether it contains a corticosteroid helps the healthcare team consider your overall medication exposure without unnecessarily changing an effective treatment plan.
Can COPD affect bones even without steroid treatment?
Yes. Bone health problems are not explained by medication alone. The COPD Foundation's information on nutrition and COPD notes that osteoporosis is among the health problems associated with COPD and discusses how inflammation and corticosteroid treatment may contribute to bone concerns.
Several other factors may influence bone strength, including smoking, limited physical activity, inadequate calcium or vitamin D intake, low body weight, older age, and a personal or family history of osteoporosis or fractures. Some people with COPD have more than one of these factors, making it important to assess their overall bone health rather than focusing on a single medicine.
- Repeated or prolonged use of oral corticosteroids.
- Long-term exposure to high doses of inhaled corticosteroids.
- Smoking or a history of smoking.
- Limited weight-bearing activity or prolonged periods of inactivity.
- Inadequate dietary calcium or vitamin D.
- A previous fragility fracture, osteoporosis, or a family history of osteoporosis.
How can you check whether your COPD treatment is affecting your bones?
Bone loss may not produce obvious symptoms in its early stages. Your healthcare professional can review your medicines alongside your medical history, age, previous fractures, smoking history, nutrition, and activity level to assess whether further evaluation is appropriate.
A bone mineral density scan, commonly called a dual-energy X-ray absorptiometry (DXA or DEXA) scan, can measure bone density and help assess fracture risk. According to MedlinePlus information on bone density, this type of assessment can identify low bone density, detect osteoporosis, and help monitor the effects of treatment. Your clinician can determine whether testing is appropriate based on your overall risk rather than inhaler use alone.
It is worth bringing an up-to-date medication list to appointments, including steroid tablets taken during previous flare-ups. Mention any history of fractures or known osteoporosis. This information can help your healthcare team decide whether bone-density testing, closer monitoring, or preventive treatment may be useful.
How can you protect bone health while taking COPD medicines?
Protecting bone health does not usually require stopping an effective COPD medicine. Instead, the goal is to maintain good respiratory control while reducing avoidable risks to the bones.
Review steroid treatment regularly
Ask your prescriber whether your corticosteroid dose remains appropriate for your current respiratory needs. If you frequently need steroid tablets for flare-ups, discuss your overall COPD management plan and ways to reduce the need for repeated courses when clinically appropriate. Do not reduce your dose, stop an inhaler, or change the timing of treatment on your own, because this could allow breathing problems to return or worsen.
Support your bones through nutrition and activity
A balanced diet containing adequate calcium, vitamin D, and protein supports bone health. Calcium-containing foods include dairy products, calcium-fortified plant-based drinks, beans, leafy green vegetables, and certain nuts and seeds. Vitamin D helps the body absorb calcium. Ask your healthcare professional whether your dietary intake is sufficient and whether supplements are appropriate for you.
Regular physical activity can also help maintain bone strength, muscle function, and balance. Suitable activities may include walking, resistance exercises, and other weight-bearing movements adapted to your breathing ability. If breathlessness or reduced mobility limits your activity, a pulmonary rehabilitation professional or physiotherapist can help you develop a suitable exercise plan.
Reduce other avoidable risks
If you smoke, seek support to stop smoking. Limiting alcohol, maintaining adequate nutrition, and taking steps to prevent falls can also support bone health. People with COPD may need to adapt physical activity to their respiratory capacity, so exercises should be chosen with guidance when existing health problems or mobility limitations are present.
Ask whether additional bone protection is needed
For people with osteoporosis, a previous fragility fracture, or substantial exposure to corticosteroids, a clinician may consider specific treatment to protect bones. The choice depends on the person's bone density, fracture risk, medical history, and other medicines. Calcium or vitamin D supplements alone may not be sufficient when osteoporosis treatment is indicated.
When should you discuss bone health with your healthcare team?
Discuss bone health during routine COPD reviews if you take high-dose inhaled corticosteroids, have needed repeated courses of steroid tablets, have a history of osteoporosis or fractures, or have other factors that may weaken bones. You should also seek medical assessment after a fracture or following a fall that causes significant injury. Persistent or new back pain, particularly after a minor injury, also deserves evaluation because some spinal fractures can occur without a major accident.
The key is to make a balanced treatment decision. Corticosteroids can be useful for controlling COPD, but their potential effects on bone health deserve attention when exposure is substantial. Reviewing your complete treatment history and individual risk factors can help your healthcare team maintain respiratory benefits while addressing bone health where needed.